Double punch therapy aims to zap prostate cancer with less harm
NCT ID NCT05345444
First seen Mar 27, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study tests a new approach for men with intermediate-risk prostate cancer. First, doctors use a special electric pulse (IRE) to destroy tumor cells, then follow up with precise radiation (MRgRT). The goal is to see if this combination is safe and can keep cancer away for at least a year. About 48 men will take part, and they will be monitored closely for side effects and cancer recurrence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.